• Revive Therapeutics closed a first tranche of a non-brokered private placement, raising gross proceeds of $246,920.
• Issued 7,716,250 units at $0.03 each; each unit includes one common share, one warrant exercisable at $0.05 for 36 months.
• Proceeds earmarked primarily for working capital.
• Paid finders $17,433.6; issued 537,300 broker warrants exercisable at $0.05 for 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revive Therapeutics Ltd. published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.